Tuberculosis treatment is expensive for patients in developing countries. [electronic resource]
- BMJ (Clinical research ed.) Jul 1997
- 187-8 p. digital
Publication Type: Comment; Letter
0959-8138
10.1136/bmj.315.7101.187a doi
Antitubercular Agents--economics Developing Countries Drug Costs Health Care Costs Humans Tuberculosis--drug therapy